ABBVIE Trademark

Trademark Overview

On Thursday, March 22, 2012, a trademark application was filed for ABBVIE with the United States Patent and Trademark Office. The USPTO has given the ABBVIE trademark a serial number of 85576479. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, April 22, 2024. This trademark is owned by Abbott Laboratories. The ABBVIE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
abbvie

General Information

Serial Number85576479
Word MarkABBVIE
Filing DateThursday, March 22, 2012
Status710 - CANCELLED - SECTION 8
Status DateMonday, April 22, 2024
Registration Number4358949
Registration DateTuesday, June 25, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, April 22, 2024
Primary Code005
First Use Anywhere DateTuesday, January 1, 2013
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameABBVIE INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNORTH CHICAGO, IL 60064
Party NameABBVIE INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNORTH CHICAGO, IL 60064
Party NameAbbvie Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbott Laboratories
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAbbott Park, IL 60064
Party NameAbbott Laboratories
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAbbott Park, IL 60064

Trademark Events

Event DateEvent Description
Monday, March 26, 2012NEW APPLICATION ENTERED
Thursday, March 29, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 25, 2012ASSIGNED TO EXAMINER
Friday, June 1, 2012EXAMINERS AMENDMENT -WRITTEN
Friday, June 1, 2012EXAMINERS AMENDMENT E-MAILED
Friday, June 1, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 1, 2012EXAMINER'S AMENDMENT ENTERED
Monday, June 11, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 2, 2012ASSIGNED TO LIE
Saturday, July 14, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 2, 2012TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, October 16, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2012ASSIGNED TO PETITION STAFF
Wednesday, October 31, 2012REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, March 19, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 19, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013SOU TEAS EXTENSION RECEIVED
Monday, March 25, 2013TEAS REQUEST TO DIVIDE RECEIVED
Monday, March 25, 2013DIVISIONAL REQUEST RECEIVED
Monday, March 25, 2013SOU EXTENSION 1 FILED
Tuesday, March 26, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 27, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, March 28, 2013DIVISIONAL PROCESSING COMPLETE
Thursday, March 28, 2013SOU EXTENSION 1 GRANTED
Friday, March 29, 2013CORRECTED NOA E-MAILED
Friday, March 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2013TEAS STATEMENT OF USE RECEIVED
Monday, April 15, 2013USE AMENDMENT FILED
Thursday, May 2, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 15, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 20, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, May 21, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 25, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, August 1, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 25, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 17, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, August 5, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 5, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, June 25, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, June 26, 2023TEAS SECTION 8 & 9 RECEIVED
Tuesday, July 11, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 18, 2024ASSIGNED TO PETITION STAFF
Saturday, April 20, 2024PETITION TO DIRECTOR DENIED
Monday, April 22, 2024CANCELLED SEC. 8 (10-YR)
Monday, April 22, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 23, 2024NOTICE OF CANCELLATION SEC. 8 EMAILED
Wednesday, July 12, 2023OFFICE ACTION ISSUED POU1
Tuesday, January 23, 2024TEAS PETITION TO DIRECTOR RECEIVED

Related Keywords

abbvie hormonal dermatological gastrointestinal neurological ophthalmic respiratory psychiatric immune disorders vaccines